脂肪性肝疾患(Fatty Liver Disease):治療薬開発パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Fatty Liver Disease - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Fatty Liver Disease Overview 10
Therapeutics Development 11
Pipeline Products for Fatty Liver Disease – Overview 11
Pipeline Products for Fatty Liver Disease – Comparative Analysis 12
Fatty Liver Disease – Therapeutics under Development by Companies 13
Fatty Liver Disease – Therapeutics under Investigation by Universities/Institutes 16
Fatty Liver Disease – Pipeline Products Glance 17
Late Stage Products 17
Clinical Stage Products 18
Early Stage Products 19
Unknown Stage Products 20
Fatty Liver Disease – Products under Development by Companies 21
Fatty Liver Disease – Products under Investigation by Universities/Institutes 23
Fatty Liver Disease – Companies Involved in Therapeutics Development 24
ACROVIS biostructures GmbH 24
ChemoCentryx, Inc. 25
Conatus Pharmaceuticals Inc. 26
Daewoong Pharmaceutical Co., Ltd. 27
Dr. Falk Pharma GmbH 28
DURECT Corporation 29
Galmed International Ltd. 30
Generon (Shanghai) Corporation Ltd. 31
Genovate Biotechnology Co., LTD. 32
Gilead Sciences, Inc. 33
Huons Co., Ltd. 34
Kyorin Pharmaceutical Co., Ltd. 35
Metabolic Solutions Development Company, LLC 36
Novartis AG 37
Protalix BioTherapeutics, Inc. 38
Raptor Pharmaceuticals Corp. 39
TCM Biotech International Corp 40
Tobira Therapeutics, Inc. 41
Verva Pharmaceuticals Limited 42
Zafgen Inc. 43
Fatty Liver Disease – Therapeutics Assessment 44
Assessment by Monotherapy Products 44
Assessment by Target 45
Assessment by Mechanism of Action 48
Assessment by Route of Administration 50
Assessment by Molecule Type 51
Drug Profiles 53
ACR-488 – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
Aramchol – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
CCX-872 – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
cenicriviroc mesylate – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
CSN-501 – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
cysteamine DR – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
Drugs to Inhibit ABHD6 for Gastrointestinal and Metabolic Disorders – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
DV-928 – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
DWP-10292 – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
emricasan – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
etanercept biosimilar – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
F-652 – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
HU-002 – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
MAT-8800 – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
MB-12066 – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
methazolamide – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
MN-002 – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
MSDC-0602 – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
norursodeoxycholic acid – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
oltipraz – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
PCBB-7 – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
pradigastat sodium – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
Px-102 – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
Px-103 – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
Px-104 – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
Recombinant Protein for Atherosclerosis and Hepatic Steatosis – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
Small Molecule to Inhibit IKK and TBK1 for Cardiovascular, Gastrointestinal and Metabolic Disorders – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
Small Molecule to Inhibit Them1 for Metabolic, Immunology and Gastrointestinal Diseases – Drug Profile 87
Product Description 87
Mechanism of Action 87
R&D Progress 87
Small Molecules to Activate AMPK for Fatty Liver Disease – Drug Profile 88
Product Description 88
Mechanism of Action 88
R&D Progress 88
SR-9238 – Drug Profile 89
Product Description 89
Mechanism of Action 89
R&D Progress 89
Synthetic Peptide for Cardiovascular, Gastrointestinal and Metabolic Disorders – Drug Profile 90
Product Description 90
Mechanism of Action 90
R&D Progress 90
TCM-606F – Drug Profile 92
Product Description 92
Mechanism of Action 92
R&D Progress 92
VVP-100-X – Drug Profile 93
Product Description 93
Mechanism of Action 93
R&D Progress 93
ZGN-839 – Drug Profile 94
Product Description 94
Mechanism of Action 94
R&D Progress 94
Fatty Liver Disease – Recent Pipeline Updates 95
Fatty Liver Disease – Dormant Projects 112
Fatty Liver Disease – Product Development Milestones 114
Featured News & Press Releases 114
Jan 12, 2015: Researchers uncover more clues to how drug reverses obesity, diabetes, fatty liver disease 114
Jul 22, 2014: Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 115
Apr 28, 2014: Galmed Pharmaceuticals Commences Patient Screening for Aramchol Pharmacokinetic and Food Effect Studies 116
Mar 03, 2014: Conatus Pharmaceuticals Extends Liver Disease Reach With Phase 2 NAFLD/NASH Trial 116
Dec 19, 2012: Scripps Florida Scientists Develop New Compound that Reverses Fatty Liver Disease 117
Oct 31, 2012: Phenex Pharma Completes Phase I Studies With FXR-Agonist Px-102 118
Oct 06, 2011: Metabolic Solutions Development Company Receives $1.1m NIH Grant To Further Investigate MSDC-0602 For Treatment Of Fatty Liver Disease 119
Oct 14, 2010: Galmed Initiates Phase II Clinical Trial Of Aramchol For Treatment Of Fatty Liver Disease 119
Sep 21, 2008: Galmed Medical Research Initiates Its Phase I study Of Aramchol, Its Drug Candidate For Fatty Liver Disease 120
Appendix 122
Methodology 122
Coverage 122
Secondary Research 122
Primary Research 122
Expert Panel Validation 122
Contact Us 122
Disclaimer 123


【レポート販売概要】

■ タイトル:脂肪性肝疾患(Fatty Liver Disease):治療薬開発パイプライン動向(2015年上半期版)
■ 英文:Fatty Liver Disease - Pipeline Review, H1 2015
■ 発行日:2015年3月11日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6261IDB
■ 調査対象地域:グローバル
  • 世界のマネージドプリントサービス(MPS: Managed Print Services)市場動向(2012-2016)
    TechNavio's analysts forecast the Global Managed Print Services (MPS) market to grow at a CAGR of 10.75 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for significant cost reduction. The Global Managed Print Services (MPS) market has also been witnessing the increase in demand for cloud service offerings. However, the lack of transparency o …
  • 世界の硝子体タンポナーデ市場2015
    The Global Vitreous Tamponades Industry Report 2015 is a professional and in-depth study on the current state of the Vitreous Tamponades industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Vitreous Tamponades market analysis is provided for the international markets including development trends, compe …
  • 炭酸アンモニウムの世界市場2019-2023
    About this market Increase in R&D activities to drive market growth. The increase in investments and technological advances in the ammonia industry are expected to drive the demand for ammonium carbonate. Technological improvements such as Haber-Bosch process improvements, catalysts and absorbents selection, and new electrochemical processes are used in the production of ammonia. Such advanced tec …
  • スタンドアップ型ポーチの世界市場:無菌性ポーチ、標準型ポーチ、レトルトポーチ
    Stand-up pouches have attracted a number of customers that have led to their wide adoption by end-users worldwide for different applications. Producers can very easily customize the shape, size and provide the buyer with additional features, as per the product requirements. Stand-up pouches consume less store capacity and have ability to stand up on shelves, thus adding up to the product’s visibil …
  • GeoPetro Resources Company:石油・ガスの開発・生産動向及びコスト分析- 2012
    GeoPetro Resources Company Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary GeoPetro Resources Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
  • 自動車用セルモーターの世界市場
    About Automotive Starter MotorA car engine is turned on at a high speed to suck in air and fuel into the combustion chamber for compression. The starter motor comprises a pinion on its shaft, which is fixed to the larger sun gear ring on the flywheel. The starter motor provides rotatory motion and cranks, and provides ignition to the engine. Technavio’s analysts forecast the global automotive star …
  • パーソナルクラウドの世界市場予測
    Cloud computing has progressed from being a newer way of computing to a proficient and cost-efficient tool for businesses to store and access data. There have been several transitions in the offerings ranging from Software as a Service (SaaS) to Infrastructure as a Service (IaaS). In addition to this, the widespread digitalization and consumerization of IT has affected the users’ digital lives, en …
  • 世界の生体用接着剤市場2015
    The Global Bioadhesive Industry Report 2015 is a professional and in-depth study on the current state of the Bioadhesive industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Bioadhesive market analysis is provided for the international markets including development trends, competitive landscape analysis …
  • 医療レポート:Ulcerative Colitis-疫学予測(~2022)
    EpiCast Report: Ulcerative Colitis - Epidemiology Forecast to 2022 Summary Ulcerative colitis is a chronic inflammatory bowel disease (IBD) that causes ulcers in the innermost lining of the colon and rectum. The colon’s ability to absorb water is decreased, which leads to progressive loosening of the stool, bloody stool, and sometimes cramping or abdominal pain with urgency for bowel movement (CDC …
  • 世界のモバイルゲーム市場:プラットフォーム別、地域別
    Global Mobile Gaming Market: About this market Technavio’s mobile gaming market analysis considers sales from both online and offline platform. Our study also finds the sales of mobile gaming in APAC, Europe, North America, South America, and MEA. In 2019, the online mobile gaming segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such …
  • ブリスター包装の世界市場2016-2020
    About Blister Packaging The pharmaceutical industry employs blister packaging to pack medicines and small medical devices as it reduces production time and offers increased product protection. The adoption of this packaging solution is the highest in this industry because of rapid growth in the demand for tamper-evident and convenient packaging. Blister packaging protects solid dose pharmaceutical …
  • 低電力広域通信網(WAN)の世界市場予測(~2021)
    The Low Power Wide Area Network (LPWAN) market size is expected to grow from USD 1.01 Billion in 2016 to USD 24.46 Billion by 2021, at an estimated Compound Annual Growth Rate (CAGR) of 89.3% during the forecast period. Major growth drivers of the LPWAN market are increasing adoption of IoT/M2M devices, rising need of long range connectivity between these devices, and low power and low cost of LPW …
  • 呼吸ケア装置の世界市場予測(~2024年)
    “High prevalence of respiratory diseases as a result of the rapid growth in the global geriatric population is expected to drive the growth of the respiratory care devices market.” The respiratory care devices market is projected to reach USD 31.8 billion by 2024 from USD 20.6 billion in 2019, at a CAGR of 9.1%. The rapid growth in the global geriatric population, rising incidence of chronic disea …
  • Anderson Energy Ltd.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    Anderson Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Anderson Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
  • 自動車用シートの世界市場予測
    The automotive seats market is undergoing change on two fronts: a shift in the industry landscape (including developing seat markets and increasingly stringent environment regulations) and changing consumer behavior and demand patterns. To remain competitive, seat manufacturers require insights that provide clear direction with regard to the growth of today’s markets and future consumer demands. T …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。